IGAMBIT INCORPORATED (OTCMKTS:IGMB)’s Stock Is Buy After Less Market Selling

February 13, 2018 - By Adrian Erickson

The stock of IGAMBIT INCORPORATED (OTCMKTS:IGMB) registered a decrease of 86.21% in short interest. IGMB’s total short interest was 1,200 shares in February as published by FINRA. Its down 86.21% from 8,700 shares, reported previously. With 4,400 shares average volume, it will take short sellers 0 days to cover their IGMB’s short positions.

The stock decreased 2.78% or $0.0011 during the last trading session, reaching $0.0384. About 7,100 shares traded. iGambit Inc. (OTCMKTS:IGMB) has 0.00% since February 13, 2017 and is . It has underperformed by 16.70% the S&P500.

iGambit Inc., focuses on the end to end software-as-a-service solutions that manages, reports, and analyzes critical data. The company has market cap of $4.78 million. It also offers fully-hosted cloud services for healthcare providers to conduct the medicare annual wellness visit program to their medicare patients with a 5-10 years personalized preventive plan, and physician reports. It currently has negative earnings. In addition, the AWV program allows a physician to identify those patients that have 2+ chronic conditions, and require additional screening and management.

More notable recent iGambit Inc. (OTCMKTS:IGMB) news were published by: Marketwired.com which released: “HealthDatix signs contract with Endeavor Plus” on October 09, 2017, also Marketwired.com with their article: “IGAMBIT Announces Acquisition of HUBCENTRIX INC. A Leading Provider of …” published on February 15, 2017, Newsday.com published: “iGambit making two high-tech acquisitions” on February 16, 2017. More interesting news about iGambit Inc. (OTCMKTS:IGMB) were released by: Marketwired.com and their article: “iGambit Inc.’s HealthDatix signs Tele-Health Wearables contract with Axcel …” published on November 02, 2017 as well as Marketwired.com‘s news article titled: “EncounterCare Solutions Announces Sale of Healthcare Program and Stock Dividend” with publication date: April 13, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: